Skip to content

CADENCE PHARMACEUTICALS INC

CIK 0001333248

← back to feed
Revenue (TTM)
$91.14M
+21.9% YoY FY Feb 2014
Net Income (TTM)
−$36.07M
+40.6% YoY FY Feb 2014
EPS Diluted (TTM)
—
FY Feb 2014
Gross Margin
26.1%
FY Feb 2014
Operating Margin
-43.2%
FY Feb 2014
Net Margin
-39.6%
FY Feb 2014
Free Cash Flow (TTM)
−$23.7M
FY Feb 2014
Cash
$55.08M
FY Feb 2014
Total Debt
$29.32M
FY Feb 2014
Shares Outstanding
89.18M sh
FY Feb 2014

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings